These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3318475)

  • 1. A double-masked study of timolol and pilocarpine combined.
    Airaksinen PJ; Valkonen R; Stenborg T; Takki K; Klemetti A; Kontkanen M; Oskala P
    Am J Ophthalmol; 1987 Dec; 104(6):587-90. PubMed ID: 3318475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timolol-pilocarpine combined vs timolol and pilocarpine given separately.
    Söderström MB; Wallin O; Granström PA; Thorburn W
    Am J Ophthalmol; 1989 May; 107(5):465-70. PubMed ID: 2653044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on the 24-hour diurnal curve of intraocular pressure of a fixed ratio combination of timolol 0.5% and pilocarpine 2% in patients with COAG not controlled on timolol 0.5%.
    Maclure GM; Vogel R; Sturm A; Binkowitz B
    Br J Ophthalmol; 1989 Oct; 73(10):827-31. PubMed ID: 2818993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined timolol and pilocarpine vs pilocarpine alone and timolol alone in the treatment of glaucoma.
    Zadok D; Geyer O; Zadok J; Lazar M; Krakowski D; Nemet P
    Am J Ophthalmol; 1994 Jun; 117(6):728-31. PubMed ID: 8198156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timolol-pilocarpine fixed-ratio combinations in the treatment of chronic open angle glaucoma. A controlled multicenter study of 48 weeks. Scandinavian Timpilo Study Group.
    Puustjärvi TJ; Repo LP
    Arch Ophthalmol; 1992 Dec; 110(12):1725-9. PubMed ID: 1342582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative evaluation of pilocarpine 1% and clonidine 0.125% versus timolol 0.5%.
    Sihota R; Agarwal HC; Rajashekar YL
    Indian J Ophthalmol; 1996 Jun; 44(2):87-9. PubMed ID: 8916595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary open-angle glaucoma. Effects of an eyedrop combining timolol and pilocarpine on the ocular pressure].
    Leroy C; Collignon-Brach J
    J Fr Ophtalmol; 1990; 13(1-2):29-32. PubMed ID: 2212504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma.
    Agarwal HC; Gupta V; Sihota R
    J Ocul Pharmacol Ther; 2003 Apr; 19(2):105-12. PubMed ID: 12804055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effect of apraclonidine on intraocular pressure in glaucoma patients receiving timolol and pilocarpine.
    Yüksel N; Elibol O; Caglar Y; Alçelik T
    Ophthalmologica; 1997; 211(6):354-7. PubMed ID: 9380353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two fixed beta-blocker-pilocarpine combinations. The Carteolol-Pilocarpine Study Group.
    Bron AM; Garcher CP; Sirbat D; Allaire CM; Lablache-Combier MJ; Trinquand CJ
    Eur J Ophthalmol; 1997; 7(4):351-6. PubMed ID: 9457458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
    Kałuzny JJ; Szaflik J; Czechowicz-Janicka K; Kałuzny J; Orzałkiewicz A; Zaleska-Zmijewska A; Krajewska M; Stewart JA; Leech JN; Stewart WC
    Klin Oczna; 2004; 106(1-2 Suppl):241-2. PubMed ID: 15510513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, long-term, randomized study of the efficacy and safety of the drug combination pilocarpine 1% with clonidine 0.06% or clonidine 0.125% versus timolol 0.25%.
    Sihota R; Rajashekhar YL; Venkatesh P; Agarwal H
    J Ocul Pharmacol Ther; 2002 Dec; 18(6):499-506. PubMed ID: 12537676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of timolol versus pilocarpine on visual field progression in patients with primary open-angle glaucoma.
    Vogel R; Crick RP; Mills KB; Reynolds PM; Sass W; Clineschmidt CM; Tipping R
    Ophthalmology; 1992 Oct; 99(10):1505-11. PubMed ID: 1454315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma.
    Konstas AG; Stewart WC; Topouzis F; Tersis I; Holmes KT; Stangos NT
    Am J Ophthalmol; 2001 Jun; 131(6):729-33. PubMed ID: 11384568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with a fixed dose combination therapy of timolol and pilocarpine used twice daily in the management of chronic open angle glaucoma.
    Moriarty AP; Dowd TC; Trimble RB
    Eye (Lond); 1994; 8 ( Pt 4)():410-3. PubMed ID: 7821462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The additional pressure-lowering effect in patients with glaucoma of pilocarpine 2 per cent, adrenaline 1 per cent, or guanethidine 3 per cent with adrenaline 0.5 per cent and timolol 0.25 per cent: a double-blind cross-over study.
    O'Connor MA; Mooney DJ
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 6)():588-92. PubMed ID: 6385355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of multiple doses of 4 and 6% timolol, and timolol combined with 2% pilocarpine in clinically normal beagles and beagles with glaucoma.
    Gelatt KN; Larocca RD; Gelatt JK; Strubbe DT; MacKay EO
    Am J Vet Res; 1995 Oct; 56(10):1325-31. PubMed ID: 8928950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%.
    Orengo-Nania S; Landry T; Von Tress M; Silver LH; Weiner A; Davis AA;
    Am J Ophthalmol; 2001 Dec; 132(6):860-8. PubMed ID: 11730649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.